FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968093827> ?p ?o ?g. }

• W1968093827 abstract "Combination therapy in managing psychiatric disorders is not uncommon. While combination therapy has been documented for depression and schizophrenia, little is known about combination therapy practices in managing attention-deficit/hyperactivity disorder (ADHD). This study seeks to quantify the combination use of ADHD medications and to understand predictors of combination therapy.Prescription dispensing events were drawn from a U.S. national claims database including over 80 managed-care plans. Patients studied were age 18 or over with at least 1 medical claim with a diagnosis of ADHD (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 314.0), a pharmacy claim for ADHD medication during the study period July 2003 to June 2004, and continuous enrollment 6 months prior to and throughout the study period. Dispensing events were grouped into 6 categories: atomoxetine (ATX), long-acting stimulants (LAS), intermediate-acting stimulants (IAS), short-acting stimulants (SAS), bupropion (BUP), and Alpha-2 Adrenergic Agonists (A2A). Events were assigned to calendar months, and months with combined use from multiple categories within patient were identified. Predictors of combination therapy for LAS and for ATX were modeled for patients covered by commercial plans using logistic regression in a generalized estimating equations framework to adjust for within-patient correlation between months of observation. Factors included age, gender, presence of the hyperactive component of ADHD, prior diagnoses for psychiatric disorders, claims history of recent psychiatric visit, insurance plan type, and geographic region.There were 18,609 patients identified representing a total of 11,886 months of therapy with ATX; 40,949 months with LAS; 13,622 months with IAS; 38,141 months with SAS; 22,087 months with BUP; and 1,916 months with A2A. Combination therapy was present in 19.7% of continuing months (months after the first month of therapy) for ATX, 21.0% for LAS, 27.4% for IAS, 23.1% for SAS, 36.9% for BUP, and 53.0% for A2A.For patients receiving LAS, being age 25-44 or age 45 and older versus being 18-24 years old, seeing a psychiatrist, having comorbid depression, or having point-of-service coverage versus a Health Maintenance Organization (HMO) resulted in odds ratios significantly greater than 1, representing increased likelihood for combination therapy in managing adult ADHD.For patients receiving ATX, being age 25-44 or age 45 and older versus being 18-24 years old, seeing a psychiatrist, having a hyperactive component to ADHD, or having comorbid depression resulted in odds ratios significantly greater than 1, representing increased likelihood for combination therapy in managing adult ADHD.ATX and LAS are the most likely drugs to be used as monotherapy. Factors predicting combination use were similar for months in which ATX was used and for months in which LAS was used except that a hyperactive component to ADHD predicted increased combination use for ATX but not for LAS." @default.
• W1968093827 created "2016-06-24" @default.
• W1968093827 creator A5015927873 @default.
• W1968093827 creator A5040259269 @default.
• W1968093827 creator A5059763098 @default.
• W1968093827 creator A5070203419 @default.
• W1968093827 creator A5071583939 @default.
• W1968093827 date "2009-06-08" @default.
• W1968093827 modified "2023-10-07" @default.
• W1968093827 title "A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)" @default.
• W1968093827 cites W1694107652 @default.
• W1968093827 cites W1970966565 @default.
• W1968093827 cites W1994020267 @default.
• W1968093827 cites W2039961483 @default.
• W1968093827 cites W2041100912 @default.
• W1968093827 cites W2046515652 @default.
• W1968093827 cites W2048364865 @default.
• W1968093827 cites W2053295943 @default.
• W1968093827 cites W2064340252 @default.
• W1968093827 cites W2082985055 @default.
• W1968093827 cites W2087008462 @default.
• W1968093827 cites W2120898017 @default.
• W1968093827 cites W2126663968 @default.
• W1968093827 cites W2129135494 @default.
• W1968093827 cites W2130386846 @default.
• W1968093827 cites W2145440976 @default.
• W1968093827 cites W2145626389 @default.
• W1968093827 cites W4292856464 @default.
• W1968093827 doi "https://doi.org/10.1186/1472-6963-9-95" @default.
• W1968093827 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2702287" @default.
• W1968093827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19505334" @default.
• W1968093827 hasPublicationYear "2009" @default.
• W1968093827 type Work @default.
• W1968093827 sameAs 1968093827 @default.
• W1968093827 citedByCount "29" @default.
• W1968093827 countsByYear W19680938272012 @default.
• W1968093827 countsByYear W19680938272013 @default.
• W1968093827 countsByYear W19680938272014 @default.
• W1968093827 countsByYear W19680938272015 @default.
• W1968093827 countsByYear W19680938272016 @default.
• W1968093827 countsByYear W19680938272017 @default.
• W1968093827 countsByYear W19680938272018 @default.
• W1968093827 countsByYear W19680938272023 @default.
• W1968093827 crossrefType "journal-article" @default.
• W1968093827 hasAuthorship W1968093827A5015927873 @default.
• W1968093827 hasAuthorship W1968093827A5040259269 @default.
• W1968093827 hasAuthorship W1968093827A5059763098 @default.
• W1968093827 hasAuthorship W1968093827A5070203419 @default.
• W1968093827 hasAuthorship W1968093827A5071583939 @default.
• W1968093827 hasBestOaLocation W19680938271 @default.
• W1968093827 hasConcept C118552586 @default.
• W1968093827 hasConcept C126322002 @default.
• W1968093827 hasConcept C187212893 @default.
• W1968093827 hasConcept C2426938 @default.
• W1968093827 hasConcept C2776412080 @default.
• W1968093827 hasConcept C2776999253 @default.
• W1968093827 hasConcept C2777112843 @default.
• W1968093827 hasConcept C2778781522 @default.
• W1968093827 hasConcept C2780211496 @default.
• W1968093827 hasConcept C2780783007 @default.
• W1968093827 hasConcept C71924100 @default.
• W1968093827 hasConcept C98274493 @default.
• W1968093827 hasConceptScore W1968093827C118552586 @default.
• W1968093827 hasConceptScore W1968093827C126322002 @default.
• W1968093827 hasConceptScore W1968093827C187212893 @default.
• W1968093827 hasConceptScore W1968093827C2426938 @default.
• W1968093827 hasConceptScore W1968093827C2776412080 @default.
• W1968093827 hasConceptScore W1968093827C2776999253 @default.
• W1968093827 hasConceptScore W1968093827C2777112843 @default.
• W1968093827 hasConceptScore W1968093827C2778781522 @default.
• W1968093827 hasConceptScore W1968093827C2780211496 @default.
• W1968093827 hasConceptScore W1968093827C2780783007 @default.
• W1968093827 hasConceptScore W1968093827C71924100 @default.
• W1968093827 hasConceptScore W1968093827C98274493 @default.
• W1968093827 hasIssue "1" @default.
• W1968093827 hasLocation W19680938271 @default.
• W1968093827 hasLocation W19680938272 @default.
• W1968093827 hasLocation W19680938273 @default.
• W1968093827 hasLocation W19680938274 @default.
• W1968093827 hasLocation W19680938275 @default.
• W1968093827 hasOpenAccess W1968093827 @default.
• W1968093827 hasPrimaryLocation W19680938271 @default.
• W1968093827 hasRelatedWork W1975343712 @default.
• W1968093827 hasRelatedWork W1990984202 @default.
• W1968093827 hasRelatedWork W2047798740 @default.
• W1968093827 hasRelatedWork W2102242652 @default.
• W1968093827 hasRelatedWork W2137490455 @default.
• W1968093827 hasRelatedWork W2357076325 @default.
• W1968093827 hasRelatedWork W2786223886 @default.
• W1968093827 hasRelatedWork W3176143056 @default.
• W1968093827 hasRelatedWork W4211158247 @default.
• W1968093827 hasRelatedWork W4283756087 @default.
• W1968093827 hasVolume "9" @default.
• W1968093827 isParatext "false" @default.
• W1968093827 isRetracted "false" @default.
• W1968093827 magId "1968093827" @default.
• W1968093827 workType "article" @default.